ROS1 and non-small cell lung carcinoma: Additionally, we explored the clinical relevance of utilizing a liquid biopsy implementing amplicon-based next-generation sequencing (NGS) using cell-free total nucleic acids (cfTNA, cfDNA, and cfRNA) in ROS1-rearranged NSCLC patients.